TherapeuticsMD, Inc. ( TXMD) - Key Metrics
TXMD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2025Q1 | ? | ? | ? | ? |
TXMD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | ? |
TXMD Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 4.00% | ? |
| 2025Q4 | 1.95% | ? |
| 2025Q3 | 8.37% | ? |
| 2025Q2 | 2.41% | ? |
| 2025Q1 | 6.42% | ? |
TXMD
Price: $1.99
52 week price:
Earnings Per Share: 0.01 USD
P/E Ratio: 212
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 688
Ebitda: -21.6 millionMarket Capitalization: 23.1 million